Wearable Injectors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Wearable Injectors Market is segmented by Type (On-Body Injectors, Off-Body Injectors), Therapy (Oncology, Autoimmune Disease, Diabetes, Cardiovascular Disease, Others), End-User, and Geography

Wearable Injectors Market Snapshot

Wearable Injectors Market
Study Period:

2018 - 2026

Base Year:


Fastest Growing Market:

Asia Pacific

Largest Market:

North America


10.4 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Certain factors that are driving the market growth include the growing prevalence of chronic diseases, technological advancements and design development, increasing concern over the hazards related to needlestick injuries, and limitations of drug delivery through a simple syringe.

With wearable injectors costing on average between USD 20 and USD 35 per unit, they can reduce the total healthcare costs, compared to the home administration of IV infusion drugs, by allowing patients to self-inject a therapy without the need of any kind of medical supervision or additional equipment. Enabling a patient to self-administer during the course of their normal daily lives, such as at home or work also creates a significant potential to improve rates of therapy compliance. 

The ability for a patient to conveniently wear a compact, disposable device on the body during the subcutaneous injection of a large dose volume may also minimize the need for less-understood technologies in development that seek to temporarily change the subcutaneous space to enable rapid injections of large dose therapies. Hence all these factors are expected to contribute to the market growth over the forecast period.

Scope of the Report

As per the scope of the report, wearable injectors are delivery systems that adhere to the body to administer larger volumes (more than 2 mL) of drug subcutaneously over an extended period. The performance of the device is not to be impacted by the patient’s posture or movement.

By Type
On-Body Injectors
Off-Body Injectors
By Therapy
Autoimmune Disease
Cardiovascular Disease
By End User
Hospitals and Clinics
Home Care
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Oncology is Expected to Hold Significant Market Share in the Therapy Segment

Wearable injectors are observing a huge increase in its adoption across the healthcare industry as cancer patients have realized the essential benefits such as a reduction in disease progression and pain. The On-body Injector is usually placed on the stomach or the back of the arm. It is applied by a nurse, usually on the last day of each chemotherapy cycle. Hence, the rise in the prevalence of cancer and cardiac ailments is one of the primary drivers for the market. 

The cancer rates could increase by 50%, i.e. to 15 million new cases by the year 2020, as per the World Cancer Report (published in April 2018). It also states that healthy lifestyles and various public health initiatives by governments and health practitioners could originate this trend, and prevent as many as one-third of cancer cases, worldwide.

Wearable Injectors Market

To understand key trends, Download Sample Report

North America Dominates the Market and Expected to do Same in the Forecast Period

According to the National Cancer Institute (NCI), in 2016, 1.6 million people were suffering from cancer, and around 0.5 million people died from cancer. This figure indicates that the prevalence of cancer is rapidly increasing in the United States. The most common cancers in the United States are breast cancer, lung cancer, prostate cancer, colon and rectum cancer, bladder cancer, and skin cancer. 

Also according to the American Diabetes Association, diabetes has a greater health impact on Americans than heart disease, substance use disorder or COPD, with 30.3 million Americans diagnosed with the illness and many more who are at risk for developing it. The prevalence of these diseases are expected to drive the growth in demand for wearable injectors all across the region.

Wearable Injectors Market

To understand geography trends, Download Sample Report

Competitive Landscape

The global wearable injectors market is moderately competitive and consists of a number of major players. Companies like Amgen, Becton, Dickinson and Company, Dexcom, Inc., Enable Injections, Insulet Corporation, Sensile Medical , Tandem Diabetes Care, Inc., Ypsomed, among others, hold the substantial market share in the wearable Injectors market.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Prevalence of Chronic Diseases

      2. 4.2.2 Technological Advancements and Design Development

      3. 4.2.3 Increasing Concern over the Hazards and Limitations Related to Needlestick

    3. 4.3 Market Restraints

      1. 4.3.1 Preference for Alternative Drug Delivery Modes

      2. 4.3.2 Unfavorable Reimbursement Structure in Developing Countries

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Type

      1. 5.1.1 On-Body Injectors

      2. 5.1.2 Off-Body Injectors

    2. 5.2 By Therapy

      1. 5.2.1 Oncology

      2. 5.2.2 Autoimmune Disease

      3. 5.2.3 Diabetes

      4. 5.2.4 Cardiovascular Disease

      5. 5.2.5 Others

    3. 5.3 By End User

      1. 5.3.1 Hospitals and Clinics

      2. 5.3.2 Home Care

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Amgen Inc.

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Dexcom, Inc.

      4. 6.1.4 Enable Injections

      5. 6.1.5 Insulet Corporation

      6. 6.1.6 Sensile Medical

      7. 6.1.7 Tandem Diabetes Care, Inc.

      8. 6.1.8 Ypsomed

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Wearable Injectors Market market is studied from 2018 - 2026.

The Wearable Injectors Market is growing at a CAGR of 10.4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

  • Becton, Dickinson and Company
  • Amgen
  • Insulet Corporation
  • Ypsomed
  • Tandem Diabetes Care, Inc.

Are the major companies operating in Wearable Injectors Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!